Evolent Health
EVH
154 hedge funds and large institutions have $434M invested in Evolent Health in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 50 reducing their positions, and 35 closing their positions.
48% more call options, than puts
Call options by funds: $1.87M | Put options by funds: $1.26M
6% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 50
7.77% less ownership
Funds ownership: 100.59% → 92.82% (-7.8%)
8% less funds holding
Funds holding: 167 → 154 (-13)
31% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 35
43% less capital invested
Capital invested by funds: $764M → $434M (-$330M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$9.22M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$7.28M |
| 3 |
Goldman Sachs
New York
|
+$3.35M |
| 4 |
DIM
DC Investments Management
Mclean,
Virginia
|
+$3.33M |
| 5 |
Bank of New York Mellon
New York
|
+$3.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$19.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.9M |
| 3 |
BlackRock
New York
|
-$6.08M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$5.84M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$5.41M |
EVH Hedge Fund Activity: Q1 2020 in Review
154 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2020, worth a combined $434M — down 43% from $764M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of EVH and 24 opened new positions — a net loss of 11 holders — while 50 trimmed existing stakes and 53 added.
The largest buyer was Bellevue Group, adding an estimated $9.22M. The largest seller was Wellington Management Group, cutting an estimated $19.4M.
- 154 institutional investors held Evolent Health (EVH) as of Q1 2020, down from 167 in Q4 2019.
- Funds reported $434M of Evolent Health stock for Q1 2020, down 43% quarter-over-quarter.
- 24 funds opened new Evolent Health positions in Q1 2020 and 35 closed out, a net change of -11 holders.
- The largest Evolent Health buyer in Q1 2020 was Bellevue Group, an estimated $9.22M added.
- The largest Evolent Health seller in Q1 2020 was Wellington Management Group, an estimated $19.4M sold.
Based on aggregated 13F filings for Q1 2020.